Atheroprotective Reverse Cholesterol Transport Pathway Is Defective in Familial Hypercholesterolemia
Authors:
- Alexina OrsoniAOAlexina Orsoni
- Zélie JuliaZJZélie Julia
- Natalie FournierNFNatalie Fournier
- Eric FrisdalEFEric Frisdal
- Emilie DucheneEDEmilie Duchene
- Eric BruckertEBEric Bruckert
- Alain CarrieACAlain Carrie
- Dominique Bonnefont-RousselotDBDominique Bonnefont-Rousselot
- John PiraultJPJohn Pirault
- Flora Saint-CharlesFSFlora Saint-Charles
- M. John ChapmanMCM. John Chapman
- 1 July 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 31 (7) , 1675-1681
Abstract
Objective—: Low high-density lipoprotein (HDL) cholesterol levels are frequently observed in familial hypercholesterolemia (FH) and might be associated with functional alterations of HDL particles that may influence their efficaciousness in the reverse cholesterol transport pathway. Methods and Results—: We evaluated key steps of the reverse cholesterol transport, ie, cellular free cholesterol efflux, cholesteryl ester transfer protein-mediated cholesteryl ester (CE) transfer from HDL to apolipoprotein B–containing lipoproteins, and hepatic HDL-CE uptake, in patients displaying FH (n=12) and in healthy normolipidemic control subjects (n=12). Large HDL2 particles isolated from FH patients displayed a reduced capacity to mediate free cholesterol efflux via both scavenger receptor-BI– and ABCG1–dependent pathways. A significant inverse relationship between scavenger receptor-BI–dependent HDL2 efflux capacity and carotid intima-media thickness ( r =−0.473; P =0.0186), as well as between ABCG1-dependent HDL2 efflux capacity and carotid intima-media thickness ( r =−0.485; P =0.0212), was detected. We also observed an elevated cholesteryl ester transfer protein-mediated CE transfer from HDL2 and HDL3 particles to low-density lipoprotein and a reduced capacity of HDL particles to deliver CEs to the liver. Conclusion—: We demonstrated that the centripetal movement of cholesterol from peripheral tissues, including the vessel wall, to feces is defective in FH, thereby emphasizing its atherogenicity.Keywords
This publication has 33 references indexed in Scilit:
- Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and AtherosclerosisNew England Journal of Medicine, 2011
- HDL superphospholipidation enhances key steps in reverse cholesterol transportAtherosclerosis, 2010
- Plasma triglyceride levels and body mass index values are the most important determinants of preβ-1 HDL concentrations in patients with various types of primary dyslipidemiaAtherosclerosis, 2010
- Stimulation of Cholesterol Efflux by LXR Agonists in Cholesterol-Loaded Human Macrophages Is ABCA1-Dependent but ABCG1-IndependentArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Torcetrapib Differentially Modulates the Biological Activities of HDL2 and HDL3 Particles in the Reverse Cholesterol Transport PathwayArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Molecular processes that handle — and mishandle — dietary lipidsJournal of Clinical Investigation, 2008
- Comparison of different cellular models measuring in vitro the whole human serum cholesterol efflux capacityEuropean Journal of Clinical Investigation, 2006
- Phenotypic variability in familial hypercholesterolaemia: an updateCurrent Opinion in Lipidology, 2002
- Scavenger receptor Bl and cholesterol traffickingCurrent Opinion in Lipidology, 1999
- LpA-I levels do not reflect preβ1-HDL levels in human plasmaAtherosclerosis, 1997